Browse studies

Find your next paid study

1 recruiting study matching your filters

MMRC Horizon Two: A Phase II Randomized Adaptive Platform Trial Integrating Novel Therapies in High-Risk-Newly Diagnosed Multiple Myeloma (MMRC-100)

The Multiple Myeloma Research Consortium (MMRC) Horizon Two trial is a master protocol, multi-center, phase II randomized adaptive platform trial designed to e…

High Risk Newly Diagnosed Multiple Myeloma

Estimated

~$10 – $7,500

Multiple Myeloma Research ConsortiumNCT07053436